0001140361-18-012008.txt : 20180305
0001140361-18-012008.hdr.sgml : 20180305
20180305165515
ACCESSION NUMBER: 0001140361-18-012008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCarthy Sean A.
CENTRAL INDEX KEY: 0001654058
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 18666911
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD.
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2018-03-01
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001654058
McCarthy Sean A.
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD, SUITE 400
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2018-03-01
4
M
0
10516
1.5749
A
15159
D
Common Stock
2018-03-01
4
M
0
9000
1.1339
A
24159
D
Common Stock
2018-03-01
4
M
0
62
0.945
A
24221
D
Common Stock
2018-03-01
4
S
0
19578
29.428
D
4643
D
Common Stock
154237
I
See footnote
Stock Option (Right to Buy)
1.5749
2018-03-01
4
M
0
10516
0.00
D
2025-02-08
Common Stock
10516
194804
D
Stock Option (Right to Buy)
1.1339
2018-03-01
4
M
0
9000
0.00
D
2021-09-20
Common Stock
9000
328143
D
Stock Option (Right to Buy)
0.945
2018-03-01
4
M
0
62
0.00
D
2023-02-25
Common Stock
62
66752
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.90, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Held in McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees.
This option vests in 48 substantially equal monthly installments starting on the last day of January 2015.
100% of the shares subject to the option are fully vested and exercisable.
/s/ Debanjan Ray, as Attorney-in-Fact for Sean A. McCarthy
2018-03-05